NCT05206175View on ClinicalTrials.gov

Demonstration of a Digital Care Program for Methamphetamine Use Disorder

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

November 14, 2022

Study Completion Date

December 31, 2022

Conditions
Methamphetamine Abuse
Interventions
OTHER

Affect Treatment Program for Methamphetamine Use Disorder

Telemedicine based group and individual therapy, drug screens, contingency management, therapeutic app engagement, psychiatric interventions for adjuvant medications.

Trial Locations (1)

10012

Affect Therapeutics, New York

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Affect Therapeutics, Inc.

INDUSTRY